Cathie Wood is one of the most vocal bulls on Wall Street when it comes to the potential of artificial intelligence (AI).

Cathie Wood, head of ARK Investment Management, usually targets tech stocks that she says have a disruptive impact, even if ...

Cathie Wood's ARK Invest offers several popular exchange-traded funds (ETFs), and they tend to be rather concentrated, with ...

AstraZeneca is a leader in cancer treatments with FDA-approved drugs. Read why AZN stock is still a 'Buy' and why the company’s future looks bright.

Financial writer discusses Warren Buffett's sales of Apple Inc., Zuckerberg's criticism, and the impact on AAPL's stock ...

EST Cathie Wood’s ARK Investment bought 133K shares of Crispr Therapeutics (CRSP) todayStay Ahead of the Market:Discover outperforming ...

Cathie Wood is one of the most closely followed investors on Wall Street. As CEO of ARK Invest, Wood has made a name for herself mostly from her high-conviction narratives around up-and-coming ...

Wood originally bought the stock back in 2021 but then exited the position in early 2022. Through the ETF, she once again established a position in the stock in May 2023.

Fed officials uncertain about inflation, Nvidia faces tightening of China chip export curbs, and more news to start your day.

HOUSTON -- Luke Lehnen accounted for five touchdowns Sunday night and North Central beat Mount Union 41-25 to win its third Division III national championship. The Cardinals (15-0) appeared in ...

Though it may not have been a win Patriots fans wanted — with the No. 1 pick in the 2025 NFL draft hanging in the balance — rookie quarterback Joe Milton III provided a breath of fresh air on ...